Aptose Biosciences Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aptose Biosciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2024.
  • Aptose Biosciences Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $119K, a 164% increase year-over-year.
  • Aptose Biosciences Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $466K, a 5.43% increase year-over-year.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2023 was $405K, a 25.8% decline from 2022.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2022 was $546K, a 1.62% decline from 2021.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2021 was $555K, a 3.35% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $466K $119K +$74K +164% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $392K $115K -$13K -10.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $405K $115K -$20K -14.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $425K $117K -$17K -12.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $442K $45K -$89K -66.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $531K $128K -$15K -10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $546K $135K -$1K -0.74% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $547K $134K -$5K -3.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $552K $134K -$6K -4.29% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $558K $143K +$3K +2.14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $555K $136K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $555K $139K +$3K +2.21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $552K $140K +$6K +4.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $546K $140K +$9K +6.87% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-02
Q4 2020 $537K $136K +$10K +7.94% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $527K $136K +$10K +7.94% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $517K $134K +$14K +11.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $503K $131K +$32K +32.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $471K $126K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $126K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $120K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $99K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.